Tomosynthesis as Primary Test for Breast Cancer Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

10,156

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2029

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

tomosynthesis + synthetic 2D

"Women will be screened for one round with tomosynthesis + synthetic 2D, two projections, double reading with consensus or arbitration, according to local protocols, for discordant readings.~After two years (one years for women 45-49 yo) women will be re-screened with digital mammography."

DIAGNOSTIC_TEST

digital mammography

"Women will be screened for one round digital mammography, two projections, double reading with consensus or arbitration, according to local protocols, for discordant readings.~After two years (one years for women 45-49 yo) women will be re-screened with digital mammography."

Trial Locations (4)

42122

Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia

Unknown

IRCCS Policlinico San Donato, Milan

Azienda Ospedaliera Universitaria Integrata, Verona

Azienda Ulss 9 Scaligera, Verona

All Listed Sponsors
collaborator

AULSS 9 Scaligera di Verona

UNKNOWN

collaborator

IRCCS Policlinico S. Donato, Milano

UNKNOWN

collaborator

Azienda Ospedaliera Universitaria Integrata Verona

OTHER

lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV